Irritable Bowel Syndrome




Abstract


Irritable bowel syndrome (IBS) is a common cause of abdominal pain, affecting one in five adults in developed countries. Although it can also occur in the pediatric and adolescent population, the age of diagnosis is before the age of 50. Women are affected more frequently than men. IBS is characterized by recurrent abdominal pain, discomfort, bloating, gas, and an associated change in bowel habits that can take the form of either diarrhea or constipation. Often mucus is present in the stool. IBS is often classified as a functional gastrointestinal disorder because of the association with depression, gastrointestinal specific anxiety, alexithymia, mood disorders, sleep disorders, perimenstrual disorders, and sexual dysfunction. Food may serve as a trigger to IBS, with spices, chocolate, beans, cabbage, cruciferous vegetables, and fruits frequently implicated. Alterations in the gut microbiota, or dysbiosis, following antibiotic usage or gastrointestinal viral, bacterial, and parasitic infections may also contribute to the pathogenesis of IBS. There appears to be a genetic predisposition to IBS with a family history being identified in approximately 30% of patients diagnosed with IBS. It has been postulated that stress-induced alterations in the brain-gut axis affecting the central and autonomic nervous system, the enteric nervous system, and the neuroendocrine and neuroimmune systems play an important role in the evolution of this disease.




Keywords

irritable bowel syndrome, abdominal pain, diarrhea, constipation, functional bowel disease, lactose intolerance, celiac disease, colonoscopy

 


ICD-10 CODE




The Clinical Syndrome


Irritable bowel syndrome (IBS) is a common cause of abdominal pain, affecting one in five adults in developed countries. Although it can also occur in the pediatric and adolescent population, the diagnosis rarely occurs before the age of 50. Women are affected more frequently than men. IBS is characterized by recurrent abdominal pain, discomfort, bloating, gas, and an associated change in bowel habits that can take the form of either diarrhea or constipation ( Fig. 76.1 ). Often mucus is present in the stool. IBS is often classified as a functional gastrointestinal disorder because of the association with depression, gastrointestinal specific anxiety, alexithymia, mood disorders, sleep disorders, perimenstrual disorders, and sexual dysfunction. Food may serve as a trigger to IBS, with spices, chocolate, beans, cabbage, cruciferous vegetables, and fruits frequently implicated. Alterations in the gut microbiota, or dysbiosis, following antibiotic usage or gastrointestinal viral, bacterial, and parasitic infections may also contribute to the pathogenesis of IBS. There appears to be a genetic predisposition to IBS with a family history being identified in approximately 30% of patients diagnosed with IBS. It has been postulated that stress-induced alterations in the brain-gut axis affecting the central and autonomic nervous system, the enteric nervous system, and the neuroendocrine and neuroimmune systems play an important role in the evolution of this disease ( Fig. 76.2 ).




FIG 76.1


Irritable bowel disease is characterized by recurrent abdominal pain, discomfort, bloating, gas, and an associated change in bowel habits that can take the form of either diarrhea or constipation.



FIG 76.2


Behavioral, affective, and cognitive processes can affect brain–gut axis functioning as a vicious circle that will amplify sensitivity, motility, and anxiety.

(Redrawn from Pellissier S, Bonaz B. The place of stress and emotions in the irritable bowel syndrome. In: Litwack G, ed. Vitamins and hormones. Academic Press; 2017:327-354; vol. 103.)




Signs and Symptoms


Patients suffering from irritable bowel syndrome will appear healthy, yet may appear tense or anxious. Abdominal examination is bland, with findings of peritoneal irritation and no abnormal mass or organomegally will be present.




Testing


The diagnosis of irritable bowel syndrome is usually made by taking a careful history. The Rome Scoring Criteria for irritable bowel syndrome will help the clinician improve the specificity and sensitivity of diagnosis and guide the physical examination and the use of additional testing ( Table 76.1 ). Basic hematology, thyroid testing, and serum chemistries are indicated in all patients suspected of having IBS. Special attention to serum calcium to rule out hyperparathyroidism and thyroid function testing is mandatory. Stool analysis to rule all occult blood, malabsorption and viral, bacterial, and parasitic infections should also be performed. Fecal calprotectin analysis may help identify intestinal mucosal inflammation. Hydrogen glucose breath analysis and lactose intolerance testing to rule our bacterial overgrowth should be considered in those patients who developed abdominal symptoms following antibiotic therapy. Sigmoidoscopy, colonoscopy, and lower gastrointestinal barium studies may also be indicated to rule out diseases including inflammatory bowel diseases that may mimic IBS.



TABLE 76.1

Diagnosis of Irritable Bowel Syndrome According to Rome III and IV Criteria for Adults and Children












Rome III Criteria Rome IV Criteria
Adults
Recurrent abdominal pain or discomfort with onset at least 6 months prior to diagnosis, associated with 2 or more of the following, at least 3 days per month in the last 3 months



  • improvement with defecation



  • onset associated with a change in frequency of stool



  • onset associated with a change in form (appearance) of stool


Children
Abdominal discomfort or pain at least one per week, for at least 2 months before diagnosis, associated with 2 or more of the following at least 25% of time



  • improvement with defecation



  • onset associated with a change in frequency of stool



  • onset associated with a change in form (appearance) of stool


No evidence of an inflammatory, anatomic, metabolic, or neoplastic process that explains the subject’s symptoms.
Additional symptoms confirming the diagnosis:



  • change in defecation rhythm >3/day or <3/week



  • change in stool consistency – excessively hard or loose



  • change in stool passage – tenesmus, a feeling of incomplete evacuation



  • stool containing mucus



  • bloating

Recurrent abdominal pain with onset at least 6 months prior to diagnosis, associated with 2 or more of the following, at least 1 day per week in the last 3 months



  • related to defecation



  • associated with a change in frequency of stool



  • associated with a change in form (appearance) of stool


Abdominal pain at least 4 days per months, for at least 2 months before diagnosis, associated with one or more of the following



  • related to defecation



  • associated with a change in frequency of stool



  • associated with a change in form (appearance) of stool


In children with constipation, the pain does not resolve with resolution of the constipation (children in whom the pain resolves have functional constipation, not irritable bowel syndrome).
After appropriate evaluation, the symptoms cannot be fully explained by another medical condition.

Only gold members can continue reading. Log In or Register to continue

Sep 9, 2019 | Posted by in PAIN MEDICINE | Comments Off on Irritable Bowel Syndrome

Full access? Get Clinical Tree

Get Clinical Tree app for offline access